Propofol Injection, Emulsion
Product Images NDC 51662-1470

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Propofol (NDC 51662-1470). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adverse 1 (Adverse Reactions 1)

Table presenting adverse reactions associated with PROPOFOL injection, emulsion at 10 mg/mL for Anesthesia/MAC Sedation and ICU Sedation. It categorizes reactions by system (Cardiovascular, Central Nervous System, Injection Site, Metabolic/Nutritional, Respiratory, Skin and Appendages) and notes frequencies and specifics such as bradycardia, arrhythmia, hypotension, apnea, rash, and hyperlipemia.*

FDA Label Image

Adverse 2 (Adverse Reactions 2)

A table listing adverse reactions categorized by body system for PROPOFOL injection, emulsion 10 mg/mL. It contrasts reported side effects under Anesthesia/MAC Sedation and ICU Sedation, detailing conditions such as cardiovascular, nervous system, respiratory, and urogenital reactions.*

FDA Label Image

Adverse 3 (Adverse Reactions 3)

A data table comparing adverse effects of a drug or drugs during Anesthesia/MAC Sedation versus ICU Sedation. Categories include Body as a Whole, Cardiovascular, Central Nervous System, Digestive, Hematologic/Lymphatic, Injection Site, Metabolic/Nutritional, Respiratory, Skin and Appendages, Special Senses, and Urogenital, listing specific symptoms and conditions for each sedation type.*

FDA Label Image

Clinical P Image (Clinical P Image)

A line graph showing plasma propofol concentration (mg/mL) versus minutes after the end of infusion. It depicts recovery curves after 1 hour, 10 hour, and 10 day infusions, with target plasma concentration and awakening time indicated.*

FDA Label Image

Clinical P Tables (Clinical P Tables)

Two tables providing dosing information for pediatric use of propofol injection. Table 1 outlines induction of anesthesia for ages birth through 16 years, showing induction doses and injection duration medians and ranges. Table 2 covers pediatric maintenance of anesthesia for age groups 2 months to 2 years, 2 to 12 years, and over 12 through 16 years, presenting maintenance dosages in mcg/kg/min along with durations in minutes and ranges.*

FDA Label Image

Dosage 1 (Dosage 1)

Table presenting dosing rates for Propofol Injectable Emulsion in preinduction anxiolysis, induction, and maintenance phases, including secondary agent usage of opioids with specific dosage ranges and timing instructions.*

FDA Label Image

Dosage 2 (Dosage 2)

Dosage and administration instructions for PROPOFOL injection emulsion 10 mg/mL from HF Acquisition Co LLC. The panel details dosing regimens by patient groups including healthy adults under 55 years, elderly, debilitated, and pediatric patients with specific dosage adjustments for general anesthesia, MAC sedation, and maintenance of anesthesia. It also highlights warnings, contraindications, and precautions related to propofol use.*

FDA Label Image

How Supplied (How Supplied)

Table presenting unit of sale and concentration for Propofol injection, emulsion. It lists NDC codes with package types: carton of 5 Fliptop vials (200 mg/20 mL), tray of 20 Fliptop vials (500 mg/50 mL), and tray of 10 Fliptop vials (1000 mg/100 mL), all at 10 mg/mL concentration.*

FDA Label Image

Indications & Usage (Indications And Usage)

A data table listing indications for the prescription drug PROPOFOL injection, emulsion, including monitored anesthesia care sedation, combined sedation and regional anesthesia, induction and maintenance of general anesthesia, and ICU sedation of intubated, mechanically ventilated patients. The table also specifies the approved patient populations for each indication, such as adults only or patients above certain ages.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Vial Labeling (Serialized Labeling Resized)

PROPOFOL 10 mg/mL injectable emulsion in a 100 mL glass vial with a blue cap. The label indicates it is for single patient use only, contains benzyl alcohol, and is for intravenous administration. Distributed by HF Acquisition Co LLC, DBA HealthFirst. The vial includes instructions to shake well before using and an expiration date of September 2021.*

FDA Label Image

Structure (Structure)

Chemical structure of propofol showing a benzene ring with two isopropyl groups and one hydroxyl group attached.*

FDA Label Image

Vial Option 1 (Vial Label Option 1)

Label for PROPOFOL Injectable Emulsion 10 mg/mL (1 g/100 mL) for intravenous administration. The 100 mL container label notes it contains benzyl alcohol and includes usage instructions such as shaking before use and single patient use only. Distributed by Hospira, Inc., the label also lists ingredients and storage conditions and bears the Hospira logo.*

FDA Label Image

Vial Option 2 (Vial Label Option 2)

Label of PROPOFOL injectable emulsion 1 g/100 mL (10 mg/mL) for intravenous administration. The 100 mL container includes specified safety information about benzyl alcohol content and microbial growth inhibition, with storage and usage instructions. Distributed by Hospira, Inc., this prescription drug label contains detailed component and handling information.*

FDA Label Image

Vial Option 3 (Vial Option 3)

Label for PROPOFOL Injectable Emulsion 1 g/100 mL (10 mg/mL) shows the product name and strength prominently on a blue background. The label states it contains benzyl alcohol and is for intravenous administration with instructions to shake well before use. It includes warnings about benzyl alcohol's microbial inhibition and storage conditions, and notes the product is made in India for Hospira, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.